Category Archives: Awards

Fairbanks Pharmaceuticals awarded UMass pilot grant

Fairbanks Pharmaceuticals was awarded a pilot grant from the UMass Office of the President’s Science and Technology Fund to screen small molecules with the goal of identifying compounds that will promote the transdifferentiation of pancreatic alpha cells into insulin secreting beta cells.

This highly competitive funding program was created by UMass to stimulate the development of high impact therapeutic candidates. Proposals were selected based on assay feasibility, medical relevance, and commercialization potential.

Fairbanks Pharmaceuticals Awarded second MLSC Intern

Fairbanks Pharmaceuticals received a second award from the Massachusetts Life Science Center to hire a new technician intern starting in July 2016. Alyssa Berthelette, a 2016 graduate from Assumption College with a degree in Biology, was selected to replace Eddie Mesiti who departed July 31 to continue his education.  Welcome Aboard Alyssa!

Fairbanks Pharmaceuticals awarded a Phase 1 SBIR grant for $192,101 by NIDDK/NIH

Dr. Alan Schneyer, CEO/CSO and Co-founder of Fairbanks Pharmaceuticals, is the Principal Investigator (PI) of an SBIR grant from The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at The National Institutes of Health (NIH). The award begins immediately and funds our research that will identify a number of candidate compounds using our proprietary screening bioassay, comparing them for biochemical and biological properties, and testing the top candidates for biological activity in islet culture assays.

The award lasts for a one year period. It is anticipated that the successful completion of this Phase 1 award will lead to a larger Phase 2 award, which will allow testing the biological activity of lead compounds in animals. The goal of Fairbanks Pharmaceuticals, and this SBIR grant, is to develop compounds that lead to regeneration of insulin-producing beta cells to replace those lost to either type 1 or type 2 diabetes and thereby partially or completely eliminate diabetes in these patients. Stay tuned for progress reports….

Fairbanks Pharmaceuticals Awarded MLSC Intern

Fairbanks Pharmaceuticals received an award from the Massachusetts Life Science Center to hire an intern starting in July 2015. Eddie MesitiAlfredo (Eddie) Mesiti, a 2014 graduate from the University of Massachusetts-Amherst with an undergraduate degree in Microbiology, was selected to fill this role.

Eddie is currently completing a Masters Degree in Applied Molecular Biotechnology.  This internship will help him in his degree program while amplifying progress in pursuing our research agenda.  Welcome Aboard Eddie!